Expression of miR-155 and miR-126 in situ in cutaneous T-cell lymphoma

APMIS

Volumn 121, Issue 11, 2013, Pages 1020-1024

  Kopp, Katharina L ^a   Ralfkiaer, Ulrik ^a   Nielsen, Boye S ^b   Gniadecki, Robert ^c   Woetmann, Anders ^a   Ødum, Niels ^a   Ralfkiaer, Elisabeth ^d  

^a Department of International Health Immunology and Microbiology ^*  (Denmark)

^b BIONEER A S   (Denmark)

^c BISPEBJERG HOSPITAL   (Denmark)

^d Rigshospitalet   (Denmark)

Author keywords

CTCL; ISH; MiR 126; MiR 155; miRNA

Indexed keywords

MICRORNA 126; MICRORNA 155;

ADULT; AGED; ARTICLE; CANCER CELL; CANCER PATIENT; CELL HETEROGENEITY; CELL NUCLEUS; CLINICAL ARTICLE; CONTROLLED STUDY; CUTANEOUS T CELL LYMPHOMA; CYTOPLASM; ENDOTHELIUM CELL; FEMALE; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; IN SITU HYBRIDIZATION; LYMPHOCYTE STRUCTURE; LYMPHOCYTIC INFILTRATION; MALE; MYCOSIS FUNGOIDES; PRIORITY JOURNAL; RNA PROBE; T LYMPHOCYTE;

CTCL; ISH; MIR-126; MIR-155; MIRNA;

ADULT; AGED; AGED, 80 AND OVER; FEMALE; HUMANS; IN SITU HYBRIDIZATION; LYMPHOMA, T-CELL, CUTANEOUS; MALE; MICRORNAS; MIDDLE AGED; SKIN NEOPLASMS;

EID: 84886235678     PISSN: 09034641     EISSN: 16000463     Source Type: Journal    
DOI: 10.1111/apm.12162     Document Type: Article

References (30)

1. Lujambio A, Lowe SW. The microcosmos of cancer. Nature 2012;482:347-55.
2. Bak RO, Mikkelsen JG. Regulation of cytokines by small RNAs during skin inflammation. J Biomed Sci 2010;1:53.
3. Ceribelli A, Satoh M, Chan EK. MicroRNAs and autoimmunity. Curr Opin Immunol 2012;24:686-91.
4. Schneider MR. microRNAs as novel players in skin development, homeostasis and disease. Br J Dermatol 2012;166:22-8.
5. Ralfkiaer U, Hagedorn PH, Bangsgaard N, Løvendorf MB, Ahler CB, Svensson L, et al. Diagnostic microRNA profiling in cutaneous T-cell lymphoma (CTCL). Blood 2011;118:5891-900.
6. van Kester MS, Ballabio E, Benner MF, Chen XH, Saunders NJ, van der Fits L, et al. miRNA expression profiling of mycosis fungoides. Mol Oncol 2011;5:273-80.
7. Narducci MG, Arcelli D, Picchio MC, Lazzeri C, Pagani E, Sampogna F, et al. MicroRNA profiling reveals that miR-21, miR486 and miR-214 are upregulated and involved in cell survival in Sézary syndrome. Cell Death Dis 2011;2:e151.
8. Marstrand T, Ahler CB, Ralfkiaer U, Clemmensen A, Kopp KL, Sibbesen NA, et al. Validation of a diagnostic miRNA classifier in cutaneous T-cell lymphomas. Leuk Lymphoma 2013. [Epub ahead of print].
9. Eriksen KW, Lovato P, Skov L, Krejsgaard T, Kaltoft K, Geisler C, et al. Increased sensitivity to interferon-alpha in psoriatic T cells. J Invest Dermatol 2005;125:936-44.
10. Kohanbash G, Okada H. MicroRNAs and STAT interplay. Semin Cancer Biol 2012;22:70-5.
11. Nielsen M, Nissen MH, Gerwien J, Zocca MB, Rasmussen HM, Nakajima K, et al. Spontaneous interleukin-5 production in cutaneous t-cell lymphoma lines is mediated by constitutively activated stat3. Blood 2002;99:973-7.
12. Brender C, Lovato P, Sommer VH, Woetmann A, Mathiesen AM, Geisler C, et al. Constitutive SOCS-3 expression protects T-cell lymphoma against growth inhibition by IFNalpha. Leukemia 2005;19:209-13.
13. Krejsgaard T, Ralfkiaer U, Clasen-Linde E, Eriksen KW, Kopp KL, Bonefeld CM, et al. Malignant cutaneous T-cell lymphoma cells express IL-17 utilizing the Jak3/Stat3 signaling pathway. J Invest Dermatol 2011;131:1331-8.
14. Krejsgaard T, Litvinov IV, Wang Y, Xia L, Willerslev-Olsen A, Koralov SB, et al., Elucidating the role of interleukin-17F in cutaneous T-cell lymphoma. Blood 2013;122:943-50.
15. Kopp KL, Ralfkiaer U, Gjerdrum LM, Helvad R, Pedersen IH, Litman T, et al. STAT5-mediated expression of oncogenic miR-155 in cutaneous T-cell lymphoma. Cell Cycle 2013;12:1939-47.
16. Moyal L, Barzilai A, Gorovitz B, Hirshberg A, Amariglio N, Jacob-Hirsch J, et al. miR-155 is involved in tumor progression of mycosis fungoides. Exp Dermatol 2013;22:431-3.
17. Nielsen BS, Jørgensen S, Fog JU, Søkilde R, Christensen IJ, Hansen U, et al. High levels of microRNA-21 in the stroma of colorectal cancers predict short disease-free survival in stage II colon cancer patients. Clin Exp Metastasis 2011;28:27-38.
18. + cutaneous T-cell lymphoma cells. Cancer Res 2008;68:1083-91.
19. Döbbeling U, Dummer R, Laine E, Potoczna N, Qin JZ, Burg G. Interleukin-15 is an autocrine/paracrine viability factor for cutaneous T-cell lymphoma cells. Blood 1998;92:252-8.
20. Kadin ME, Vonderheid EC. Targeted therapies: Denileukin diftitox - a step towards a 'magic bullet' for CTCL. Nat Rev Clin Oncol 2010;7:430-2.
21. Kopp KL, Kauczok CS, Lauenborg B, Krejsgaard T, Eriksen KW, Zhang Q, et al. COX-2-dependent PGE(2) acts as a growth factor in mycosis fungoides (MF). Leukemia 2010;24:1179-85.
22. Krejsgaard T, Gjerdrum LM, Ralfkiaer E, Lauenborg B, Eriksen KW, Mathiesen AM, et al. Malignant Tregs express low molecular splice forms of FOXP3 in Sézary syndrome. Leukemia 2008;22:2230-9.
23. Lauenborg B, Kopp K, Krejsgaard T, Eriksen KW, Geisler C, Dabelsteen S, et al. Programmed cell death-10 enhances proliferation and protects malignant T cells from apoptosis. APMIS 2010;118:719-28.
24. Wang S, Aurora AB, Johnson BA, Qi X, McAnally J, Hill JA, et al. The endothelial-specific microRNA miR-126 governs vascular integrity and angiogenesis. Dev Cell 2008;15:261-71.
25. Anand S, Cheresh DA. Emerging role of micro-RNAs in the regulation of angiogenesis. Genes Cancer 2011;2:1134-8.
26. Krejsgaard T, Vetter-Kauczok CS, Woetmann A, Lovato P, Labuda T, Eriksen KW, et al. Jak3- and JNK-dependent vascular endothelial growth factor expression in cutaneous T-cell lymphoma. Leukemia 2006;20:1759-66.
27. Karpova MB, Fujii K, Jenni D, Dummer R, Urosevic-Maiwald M. Evaluation of lymphangiogenic markers in Sézary syndrome. Leuk Lymphoma 2011;52:491-501.
28. Pedersen IH, Willerslev-Olsen A, Vetter-Kauczok C, Krejsgaard T, Lauenborg B, Kopp KL, et al. Vascular endothelial growth factor receptor-3 expression in mycosis fungoides. Leuk Lymphoma 2013;54:819-26.
29. Li Z, Chen J. In vitro functional study of miR-126 in leukemia. Methods Mol Biol 2011;676:185-95.
30. Olsen E, Vonderheid E, Pimpinelli N, Willemze R, Kim Y, Knobler R, et al. Revisions of the staging and classification of mycosis fungoides and Sezary syndrome: a proposal of the International Society for Cutaneous Lymphomas (ISCL) and the cutaneous lymphoma task force of the European Organization of Research and Treatment of Cancer (EORTC). Blood 2007;110:1713-22.